Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Cohort Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA® Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding

NCT02319460 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT02319460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02319460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Cohort Study of the Risk of Thromboembolic Events Among Adult Patients Treated With KCENTRA® Compared With Plasma for Urgent Reversal of Vitamin K Antagonist Therapy in the Setting of Acute Major Bleeding
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Completed
Start date
April 24, 2014
Completion date
June 30, 2020
Enrollment
2,238 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage